Brian A Van Tine

Brian A Van Tine

UNVERIFIED PROFILE

Are you Brian A Van Tine?   Register this Author

Register author
Brian A Van Tine

Brian A Van Tine

Publications by authors named "Brian A Van Tine"

Are you Brian A Van Tine?   Register this Author

61Publications

1592Reads

30Profile Views

Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.

Lancet Oncol 2019 Sep 24;20(9):1295-1305. Epub 2019 Jul 24.

Division of Medical Oncology, Washington University School of Medicine, St Louis, MO, USA; Alvin J Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30405-XDOI Listing
September 2019

Arginine Starvation and Docetaxel Induce c-Myc-Driven hENT1 Surface Expression to Overcome Gemcitabine Resistance in ASS1-Negative Tumors.

Clin Cancer Res 2019 Aug 21;25(16):5122-5134. Epub 2019 May 21.

Division of Medical Oncology, Washington University in St. Louis, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-0206DOI Listing
August 2019

Incidence and Management of Olaratumab Infusion-Related Reactions.

J Oncol Pract 2019 Jul 3:JOP1800761. Epub 2019 Jul 3.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00761DOI Listing
July 2019

Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.

J Geriatr Oncol 2019 May 22. Epub 2019 May 22.

Royal Marsden NHS Foundation Trust, London, UK; Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2019.05.008DOI Listing
May 2019

How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centers.

Curr Med Res Opin 2019 Apr 4;35(4):623-629. Epub 2019 Feb 4.

b Division of Hematology and Oncology, Department of Medicine , University of Miami Miller School of Medicine , Miami , FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2019.1570768DOI Listing
April 2019

Sorafenib for Advanced and Refractory Desmoid Tumors.

N Engl J Med 2018 12;379(25):2417-2428

From Memorial Sloan Kettering Cancer Center and Weill Cornell Medical Center (M.M.G., W.D.T., N.H., N.P.A., R.A.L., Y.M., R.Y.) and Columbia University Vagellos College of Physicians and Surgeons and New York Presbyterian Hospital (L.H.S., G.K.S.), New York, and Northwell Cancer Institute and Cold Spring Harbor Laboratory, Lake Success (R.G.M.) - all in New York; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN (M.R.M.); Washington University School of Medicine, St. Louis (B.A.V.T.); M.D. Anderson Cancer Center, University of Texas, Houston (V.R.); Mayo Clinic in Florida, Jacksonville (S.A.); Yale University, New Haven, CT (H.A.D.); University Health Network Princess Margaret Cancer Centre, Toronto (A.A.G.); University of Iowa-Holden Comprehensive Cancer Center, Iowa City (M.M.M.); University of Alabama at Birmingham Cancer Center, Birmingham (R.M.C.); Fox Chase Cancer Center, Philadelphia (S.M.); Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC (M.J.P.); Duke Cancer Institute, Duke University Medical Center, Durham (R.F.R.), and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill (E.B.) - both in North Carolina; Dayton National Cancer Institute Community Oncology Research Program, Dayton, OH (T.S.); National Cancer Institute, Bethesda, MD (J.J.W.); and the Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ (A.C.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1805052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447029PMC
December 2018

Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review.

Cancers (Basel) 2018 Nov 1;10(11). Epub 2018 Nov 1.

Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://www.mdpi.com/2072-6694/10/11/417
Publisher Site
http://dx.doi.org/10.3390/cancers10110417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267101PMC
November 2018

Driver Fusions and Their Implications in the Development and Treatment of Human Cancers.

Cell Rep 2018 04;23(1):227-238.e3

Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO 63108, USA; Department of Genetics, Washington University in St. Louis, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.03.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916809PMC
April 2018

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

J Clin Oncol 2017 Oct 30;35(30):3433-3439. Epub 2017 Aug 30.

George D. Demetri, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium; Giovanni Grignani, Fondazione del Piemonte per l'Oncologia Istituto di Ricovero e Cura a Carattere Scientifico, Candiolo, Italy; Jean-Yves Blay, Université Claude Bernard and Centre Léon Bérard, Lyon, France; Robert G. Maki, Monter Cancer Center, Lake Success; and Cold Spring Harbor Laboratory, New Hyde Park, NY; Brian A. Van Tine, Barnes and Jewish Hospital, Washington University in St. Louis, St. Louis, MO; Thierry Alcindor, McGill University Health Centre, Montreal, Quebec, Canada; Robin L. Jones, The Royal Marsden Hospital, Institute of Cancer Research, London, United Kingdom; David R. D'Adamo and Matthew Guo, Eisai, Woodcliff Lake, NJ; and Sant Chawla, Sarcoma Oncology Center, Santa Monica, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.6605DOI Listing
October 2017

Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.

Bone 2017 Aug 21;101:145-155. Epub 2017 Apr 21.

McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Division of Genomics and Bioinformatics, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2017.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518630PMC
August 2017

Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review.

J Gastrointest Oncol 2017 Jun;8(3):466-473

Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jgo.2016.09.15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506287PMC
June 2017

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors.

Sarcoma 2017 4;2017:3761292. Epub 2017 May 4.

Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/3761292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435903PMC
May 2017

Therapeutic arginine starvation in ASS1-deficient cancers inhibits the Warburg effect.

Mol Cell Oncol 2017 1;4(3):e1295131. Epub 2017 Mar 1.

Division of Medical Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/23723556.2017.1
Publisher Site
http://dx.doi.org/10.1080/23723556.2017.1295131DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462516PMC
March 2017

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

J Clin Oncol 2016 11 30;34(32):3898-3905. Epub 2016 Sep 30.

Christopher W. Ryan, Oregon Health & Science University, Portland, OR; Ofer Merimsky, Sackler School of Medicine, Tel-Aviv, Israel; Mark Agulnik, Northwestern University, Chicago, IL; Jean-Yves Blay, Centre Léon Bérard, Lyon; Antoine Italiano, Institut Bergonié, Bordeaux, France; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Robin L. Jones and Ian R. Judson, The Royal Marsden Hospital, London, United Kingdom; Anthony D. Elias, University of Colorado-Denver, Aurora, CO; Edwin Choy, Massachusetts General Hospital; Jill Y. Buck and Francois Lebel, ZIOPHARM Oncology, Boston, MA; Thierry Alcindor, McGill University Health Center, Montreal, Quebec, Canada; Vicki L. Keedy, Vanderbilt University Medical Center, Nashville, TN; Damon R. Reed, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Robert N. Taub, Columbia University Medical Center; Jonathan J. Lewis, Samus Therapeutics and Molecular Ninja Group; Robert G. Maki, Mount Sinai School of Medicine, New York, NY; Xavier Garcia del Muro, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain; and Patrick Schöffski, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6684DOI Listing
November 2016

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications.

Oncotarget 2016 Mar;7(11):13082-92

Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7552DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914343PMC
March 2016

Novel treatment targets in sarcoma: more than just the GIST.

Am Soc Clin Oncol Educ Book 2014 :e488-95

From the Sarcoma Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY; Division of Oncology, Washington University in St. Louis School of Medicine, St. Louis, MO; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://meetinglibrary.asco.org/content/11400488-144
Publisher Site
http://dx.doi.org/10.14694/EdBook_AM.2014.34.e488DOI Listing
November 2015

The Metastatic Spine Disease Multidisciplinary Working Group Algorithms.

Oncologist 2015 Oct 9;20(10):1205-15. Epub 2015 Sep 9.

Mallinckrodt Institute of Radiology, Department of Radiation Oncology, Department of Internal Medicine, and Department of Orthopaedic Surgery, Washington University School of Medicine, Saint Louis, Missouri, USA; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA; Neurooncology Program, H. Lee Moffitt Cancer Center and Research Institute, Department of Neurosurgery, and Department of Orthopedics, University of South Florida College of Medicine, Tampa, Florida, USA; Department of Interventional Radiology, University of Strasbourg School of Medicine, Strasbourg, France; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA; Department of Anesthesiology and Pain Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591956PMC
October 2015

Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.

Cell Res 2014 Nov 30;24(11):1354-66. Epub 2014 Sep 30.

1] Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA [2] Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA [3] Department of Medicine, Weill Cornell Medical College, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cr.2014.129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220155PMC
November 2014

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.

J Clin Oncol 2014 Oct 2;32(29):3299-306. Epub 2014 Sep 2.

Sant P. Chawla, Sarcoma Oncology Center, Santa Monica; Andrew E. Hendifar, Cedars Sinai Medical Center, Los Angeles; Stew Kroll, Threshold Pharmaceuticals, South San Francisco; Kristen N. Ganjoo, Stanford University Medical Center, Stanford, CA; Lee D. Cranmer, University of Arizona Cancer Center, Tucson, AZ; Brian A. Van Tine and Douglas R. Adkins, Washington University in St Louis, St Louis, MO; Damon R. Reed, Moffitt Cancer Center and Research Institute, Tampa, FL; Scott H. Okuno, Mayo Clinic, Rochester, MN; and James E. Butrynski, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.3660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588714PMC
October 2014

Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.

Oncotarget 2014 Oct;5(19):9281-94

Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253434PMC
http://dx.doi.org/10.18632/oncotarget.2423DOI Listing
October 2014

Using molecular profiling diagnostics to identify predictive biomarkers in metastatic cancer.

Authors:
Brian A Van Tine

MLO Med Lab Obs 2014 Sep;46(9):18, 20-1

View Article

Download full-text PDF

Source
September 2014

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy.

Cancer Med 2014 Jun 27;3(3):603-12. Epub 2014 Feb 27.

Division of Medical Oncology, Washington University in St. Louis, St. Louis, 63110, Missouri; College of Medicine, Des Moines University, Des Moines, 50312, Iowa.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101751PMC
June 2014

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

BRAFV600E mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.

Neuro Oncol 2014 Mar 22;16(3):466-7. Epub 2013 Dec 22.

Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri (A.C.H., B.V.T.); Department of Pathology and Immunology, UCSF School of Medicine, San Francisco, California (M.P., A.P.); Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri (S.D.); Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri (A.J.A.); Department of Neurology, Washington University School of Medicine, St. Louis, Missouri (D.H.G.).

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/not248DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922521PMC
March 2014

Novel pathways and molecular targets for the treatment of sarcoma.

Curr Oncol Rep 2013 Aug;15(4):378-85

Division of Medical Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0319-3DOI Listing
August 2013

ER and PI3K independently modulate endocrine resistance in ER-positive breast cancer.

Cancer Discov 2011 Sep;1(4):287-8

Division of Oncology, Department of Medicine, Washington University in Saint Louis, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
http://cancerdiscovery.aacrjournals.org/cgi/doi/10.1158/2159
Publisher Site
http://dx.doi.org/10.1158/2159-8290.CD-11-0192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215586PMC
September 2011

Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning.

J Natl Cancer Inst 2011 Apr 29;103(7):526-7. Epub 2011 Mar 29.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr072DOI Listing
April 2011

Taspase1 functions as a non-oncogene addiction protease that coordinates cancer cell proliferation and apoptosis.

Cancer Res 2010 Jul 1;70(13):5358-67. Epub 2010 Jun 1.

Departments of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-0027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909739PMC
July 2010

Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.

Glycobiology 2006 Jun 27;16(6):551-63. Epub 2006 Feb 27.

Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/glycob/cwj096DOI Listing
June 2006

Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence.

Methods Mol Biol 2005 ;292:215-30

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-848-x:215DOI Listing
March 2005

Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning.

Proc Natl Acad Sci U S A 2004 Mar 12;101(12):4030-5. Epub 2004 Mar 12.

Department of Molecular Pathology, University of Alabama at Birmingham, 1918 University Boulevard, Birmingham, AL 35294-0005, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.0306848101
Publisher Site
http://dx.doi.org/10.1073/pnas.0306848101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC384690PMC
March 2004

mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication.

J Virol 2003 Oct;77(19):10213-26

Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC228435PMC
http://dx.doi.org/10.1128/jvi.77.19.10213-10226.2003DOI Listing
October 2003

Differential expression and biodistribution of cytokeratin 18 and desmoplakins in non-small cell lung carcinoma subtypes.

Lung Cancer 2002 May;36(2):133-41

Department of Medicine, University of Alabama at Birmingham, and Birmingham VAMC, 701 South 19th Street, LHRB 339, 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(01)00486-xDOI Listing
May 2002